Correlation of Heart Rate and Cardiac Dysfunction in Duchenne Muscular Dystrophy

被引:0
|
作者
Tamara O. Thomas
Thomas M. Morgan
William B. Burnette
Larry W. Markham
机构
[1] University of Cincinnati,Department of Pediatrics
[2] Cincinnati Children’s Hospital Medical Center,Department of Pediatric Medical Genetics
[3] Vanderbilt University,Department of Neurology
[4] Monroe Carell Jr Children’s Hospital at Vanderbilt,Division of Pediatric Cardiology, Department of Pediatrics
[5] Vanderbilt University,undefined
[6] Monroe Carell Jr Children’s Hospital at Vanderbilt,undefined
[7] Vanderbilt University,undefined
[8] Monroe Carell Jr Children’s Hospital at Vanderbilt,undefined
来源
Pediatric Cardiology | 2012年 / 33卷
关键词
Cardiomyopathy; Duchenne; Muscular dystrophy; Tachycardia;
D O I
暂无
中图分类号
学科分类号
摘要
Sinus tachycardia is common in cases of Duchenne muscular dystrophy (DMD). The authors hypothesized that an elevated heart rate would herald cardiomyopathy onset. A retrospective case-control study was performed with 55 DMD boys and 150 age-matched control boys. The variables were age, heart rate, shortening fraction, and left ventricular end-diastolic dimension. Cardiomyopathy was defined as a shortening fraction less than 28%. The DMD boys had a higher initial heart rate with no baseline echocardiographic evidence of cardiomyopathy. The control subjects showed a statistically significant age-related decline in heart rate (p = 0.001) but not the DMD boys. Cardiomyopathy developed in 17 of the 55 DMD boys over a period of 4.6 ± 1.6 years. The DMD upper and lower heart rate groups were similar in age, follow-up time, and initial shortening fraction, yet cardiomyopathy developed in 14 (42%) of 33 upper quartile boys but only 3 (14%) of 22 lower quartile DMD boys (odds ratio, 6.5 (95% confidence interval, 1.15–18.92; p < 0.05). Compared with the control subjects, the DMD boys had a higher resting heart rate and a lack of age-related heart rate decline. The DMD boys in the upper heart rate quartile were more likely to progress to cardiomyopathy than those in the lower quartiles. This study establishes heart rate elevation as a statistically significant risk factor for cardiomyopathy. Further studies may define heart rate cutoffs for early pharmacologic intervention for incipient cardiomyopathy.
引用
收藏
页码:1175 / 1179
页数:4
相关论文
共 50 条
  • [1] Correlation of Heart Rate and Cardiac Dysfunction in Duchenne Muscular Dystrophy
    Thomas, Tamara O.
    Morgan, Thomas M.
    Burnette, William B.
    Markham, Larry W.
    [J]. PEDIATRIC CARDIOLOGY, 2012, 33 (07) : 1175 - 1179
  • [2] Pathophysiology and Therapy of Cardiac Dysfunction in Duchenne Muscular Dystrophy
    Judge, Daniel P.
    Kass, David A.
    Thompson, W. Reid
    Wagner, Kathryn R.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2011, 11 (05) : 287 - 294
  • [3] Pathophysiology and Therapy of Cardiac Dysfunction in Duchenne Muscular Dystrophy
    Daniel P. Judge
    David A. Kass
    W. Reid Thompson
    Kathryn R. Wagner
    [J]. American Journal of Cardiovascular Drugs, 2011, 11 : 287 - 294
  • [4] Heart Rate Variability and Cardiopulmonary Dysfunction in Patients with Duchenne Muscular Dystrophy: A Systematic Review
    Talita Dias da Silva
    Thais Massetti
    Tânia Brusque Crocetta
    Carlos Bandeira de Mello Monteiro
    Alex Carll
    Luiz Carlos Marques Vanderlei
    Carlie Arbaugh
    Fernando Rocha Oliveira
    Luiz Carlos de Abreu
    Celso Ferreira Filho
    John Godleski
    Celso Ferreira
    [J]. Pediatric Cardiology, 2018, 39 : 869 - 883
  • [5] Heart Rate Variability and Cardiopulmonary Dysfunction in Patients with Duchenne Muscular Dystrophy: A Systematic Review
    da Silva, Talita Dias
    Massetti, Thais
    Crocetta, Tania Brusque
    de Mello Monteiro, Carlos Bandeira
    Carll, Alex
    Marques Vanderlei, Luiz Carlos
    Arbaugh, Carlie
    Oliveira, Fernando Rocha
    de Abreu, Luiz Carlos
    Filho, Celso Ferreira
    Godleski, John
    Ferreira, Celso
    [J]. PEDIATRIC CARDIOLOGY, 2018, 39 (05) : 869 - 883
  • [6] Heart Rate Variability and Hypercapnia in Duchenne Muscular Dystrophy
    Mochizuki, Hitoshi
    Okahashi, Satomi
    Ugawa, Yoshikazu
    Tamura, Takuhisa
    Suzuki, Mikiya
    Miyatake, Satoko
    Shigeyama, Toshiki
    Ogata, Katsuhisa
    Kawai, Mitsuru
    [J]. INTERNAL MEDICINE, 2008, 47 (21) : 1893 - 1897
  • [7] Cardiac Dysfunction in Duchenne Muscular Dystrophy: Role of Connexin 43
    Fraidenrach, Diego
    Gonzalez, Patrick
    Shirokova, Natalia
    Ramachandran, Jayalakshmi
    Contreras, Jorge E.
    [J]. JOURNAL OF GENERAL PHYSIOLOGY, 2016, 148 (02): : 11A - 11A
  • [8] Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy
    Mourkioti, Foteini
    Kustan, Jackie
    Kraft, Peggy
    Day, John W.
    Zhao, Ming-Ming
    Kost-Alimova, Maria
    Protopopov, Alexei
    DePinho, Ronald A.
    Bernstein, Daniel
    Meeker, Alan K.
    Blau, Helen M.
    [J]. NATURE CELL BIOLOGY, 2013, 15 (08) : 895 - U300
  • [9] CAVEOLAR DYSFUNCTION AS A NEWPLAYER IN CARDIAC DISEASE IN DUCHENNE MUSCULAR DYSTROPHY
    Marrosu, Elena
    Wang, Hong
    Johnson, Eric
    Scott, Charlotte
    Hau, Kwan-Leong
    Zhang, Liwen
    Duan, Nalinda Wasala Dongsheng
    Montanaro, Federica
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (02) : 274 - 275
  • [10] Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy
    Foteini Mourkioti
    Jackie Kustan
    Peggy Kraft
    John W. Day
    Ming-Ming Zhao
    Maria Kost-Alimova
    Alexei Protopopov
    Ronald A. DePinho
    Daniel Bernstein
    Alan K. Meeker
    Helen M. Blau
    [J]. Nature Cell Biology, 2013, 15 : 895 - 904